Diagast SAS, headquartered in France, is a leading player in the biotechnology and diagnostics industry, specialising in innovative solutions for blood transfusion and organ transplantation. Founded in 2004, the company has made significant strides in developing advanced immunohematology products that enhance patient safety and streamline laboratory processes. With a strong presence in Europe and expanding operations globally, Diagast offers a unique range of products, including automated systems and reagents that facilitate precise blood typing and compatibility testing. Their commitment to quality and innovation has positioned them as a trusted partner in healthcare, recognised for their contributions to improving transfusion practices. Notably, Diagast's cutting-edge technology and dedication to research have earned them a prominent market position, making them a key player in the field of transfusion diagnostics.
How does Diagast SAS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Diagast SAS's score of 11 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Diagast SAS, headquartered in France, currently does not have available carbon emissions data for the most recent year, nor does it report any specific reduction targets or initiatives. The company has not disclosed any commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As such, there are no emissions figures, such as Scope 1, 2, or 3 emissions, to report. In the absence of specific data, it is important to note that many organisations in the industry are increasingly focusing on sustainability and carbon reduction strategies. Diagast SAS may be expected to align with these trends in the future, but no concrete information is available at this time regarding their climate commitments or performance.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Diagast SAS has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

